Table 1. Initial DKR-ATH Studies of 1a with Catalyst 2aa
entry
solvent
2a (mol %)b
timec (h)
Et3Nd (equiv)
HCO2Hd (equiv)
convne (%)
3a:4af (HPLC)
% eeg 3a
1
2
3
4
5
6
7
8
CH2Cl2
EtOAc
MeCN
PhCH3
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
2
2
2
2
2
2
2
0.5
0.5
0.5
0.5
20
48
60
20
20
20
20
21
18
15k
40l
5
5
5
5
2
5
5
5
99
97
90
98
100
99
91:9
80:20
77:23
89:11
94:6
94:6
94:6
94:6
95:5
94:6
95:5
84.7
74.2
76.4
81.0
88.0
87.1
88.5
87.3
92.7
87.6
92.3
5
2h
2
2h
2i
2
2i
98
2
100
100
100
96
9
10
11
1
1
1
1.2j
1.2j
1.2j
a [1] ) 10 mL/g of solvent, 200 mg scale. b Isolated or in situ generated catalyst. c Required time to reach the conversion. d Unless noted otherwise,
added all at once in the beginning of the reaction. e HPLC analysis. f Sum of syn-epimers:sum of anti-epimers in the crude reaction mixture as analyzed by
HPLC and confirmed by NMR and X-ray single crystal structure, where the major syn-3a epimer has configuration of (2R,3R,6S) and the major anti-4a
epimer (2R,3S,6S). g See ref 12. h Added over 2 h. i Added as a 1:1 mixture over 2 h. j Added over 8 h. k 40 °C. l 23 °C.
active ꢀ-hydroxyamides.6 These types of products, as well
as their 1,3-amino alcohol derivatives,7 have been widely
used as synthetic building blocks to access many natural
products and advanced pharmaceutical intermediates, includ-
ing various potent ꢀ-lactam (azetidinone) derivatives.8
Herein, we wish to report the first enantio- and diastereo-
selective approach to R-alkyl-substituted syn-ꢀ-hydroxya-
mides via highly efficient catalytic DKR-ATH reactions
from the corresponding racemic ꢀ-ketoamides.9
Using compound 1a as a test substrate,10 our DKR-ATH
studies were initially performed with Noyori’s p-cymene-
TsDPEN ruthenium(II) chloride complex 2a. Considering that
optically active R-substituted ꢀ-ketoamides have been previ-
ously prepared via a chiral auxiliary methodology,11 the rate
of R-epimerization for our ketoamide substrate was unknown
at the time. Gratifyingly, we found that subjection of 1a to 2
mol % of 2a and 5 mol equiv of each Et3N and HCO2H at 30
°C resulted in high conversions to give the corresponding
alcohols in various solvents (entries 1-4, Table 1), with CH2Cl2
yielding the highest diastereoselectivity and enantioselectivity12
for the syn-hydroxyamide (2R,3R,6S)-3a.13 The observed high
enantio- and diastereoselectivity for the syn epimers indicates
that the R-epimerization event certainly takes place under these
conditions. Upon reducing the amounts of base and hydride
donor to 2 equiv each, higher de and ee were both observed,
regardless of the order of addition (entries 5-7). Furthermore,
performing the reaction with a reduced amount of catalyst
(0.5 mol %) did not result in the erosion of de and ee
(entry 8). Better results were obtained when performing
(4) For representatiVe examples, see: (a) Makino, K.; Hiroki, Y.;
Hamada, Y. J. Am. Chem. Soc. 2005, 127, 5784. (b) Makino, K.; Goto, T.;
Hiroki, Y.; Hamada, Y. Angew. Chem., Int. Ed. Engl. 2004, 43, 882. (c)
Lei, A.; Wu, S.; He, M.; Zhang, X. J. Am. Chem. Soc. 2004, 126, 9685. (d)
Mordant, C.; Dunkelmann, P.; Ratovelomanana-Vidal, V.; Genet, J.-P. Eur.
J. Org. Chem. 2004, 3017. (e) Mordant, C.; Dunkelmann, P.; Ratovelo-
manana-Vidal, V.; Genet, J. P. Chem. Commun. 2004, 1296.
(5) (a) Ros, A.; Magriz, A.; Dietrich, H.; Lassaletta, J. M.; Ferna´ndez,
R. Tetrahedron 2007, 63, 7532. (b) Ferna´ndez, R.; Ros, A.; Magriz, A.;
Dietrich, H.; Lassaletta, J. M. Tetrahedron 2007, 63, 6755. (c) Alcock, N. J.;
Mann, I.; Peach, P.; Wills, M. Tetrahedron: Asymmetry 2002, 13, 2485.
(d) Mohar, B.; Valleix, A.; Desmurs, J.-R.; Felemez, M.; Wagner, A.;
Mioskowski, C. Chem. Commun. 2001, 2572.
(6) For an example of enzymatic DKR-ATH of 2-oxocyclopentanecar-
boxamides, see: Quiro´s, M.; Rebolledo, F.; Gotor, V. Tetrahedron:
Asymmetry 1999, 10, 473.
(9) For examples of nonasymmetric, but diastereoselective, reduction
of racemic R-substituted ꢀ-ketoamides, see: (a) Bartoli, G.; Bosco, M.;
Marcantoni, E.; Melchiorre, P.; Rinaldi, S.; Sambri, L. Synlett 2004, 1, 73.
(b) Bartoli, G.; Bosco, M.; Dalpozzo, R.; Marcantoni, E.; Massaccesi, M.;
Rinaldi, S.; Sambri, L. Tetrahedron Lett. 2001, 42, 8811. (c) Fujita, M.;
Hiyama, T. J. Am. Chem. Soc. 1985, 107, 8294.
(7) For reviews, see: (a) Knapp, S. Chem. ReV. 1995, 95, 1859. (b)
Ohfune, H. Acc. Chem. Res. 1992, 25, 360.
(8) For representatiVe examples, see: (a) Brandi, A.; Cicchi, S.; Cordero,
F. M. Chem. ReV. 2008, 108, 3988. (b) Alcaide, B.; Almendros, P.;
Aragoncillo, C. Chem. ReV. 2007, 107, 4437. (c) Thiruvengadam, T. K.;
Sudhakar, A., R.; Wu, G. Process Chemistry in the Pharmaceutical Industry;
Gadamasetti, K. G., Ed.; Marcel Dekker, Inc.: New York, NY, 1999; p
221. (d) De´ziel, R.; Malenfant, E. Bioorg. Med. Chem. Lett. 1998, 8, 1437.
(e) Clader, J. W.; Burnett, D. A.; Caplen, M. A.; Domalski, M. S.; Dugar,
S.; Vaccaro, W.; Sher, R.; Browne, M. E.; Zhao, H.; Burrier, R. E.;
Salisbury, B.; Davis, H. R. J. Med. Chem. 1996, 39, 3684. (f) Wild, H.;
Kant, J.; Walker, D. G.; Ojima, I.; Ternansky, R. J.; Morin, J. M., Jr.; Georg,
G. I.; Rabikumar, V. T. The Organic Chemistry of ꢀ-Lactams; Georg, G. I.,
Ed.; VCH: New York, 1993.
(10) See Supporting Information for the synthesis of this compound.
(11) Evans, D. A.; Ennis, M. D.; Le, T. J. Am. Chem. Soc. 1984, 106,
1154.
(12) For ease of discussion, the term “enantioselectivity” refers to the
absolute configuration at carbon 2 and 3 of the syn-epimer 3a while ignoring
the fixed stereocenter at the benzylic carbon labeled 6 [i.e., (2R,3R,6S) vs
(2S,3S,6S)].
(13) The absolute stereochemistry was confirmed by X-ray single-crystal
structure (see Supporting Information). Additional information can be found
at the Cambridge Crystallographic Data Centre (CCDC) with deposition
code of CCDC 752316.
Org. Lett., Vol. 12, No. 3, 2010
513